Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Authorization & Regulatory Support and Others), Application (Dogs, Cats, and Others), End User (Oncology, Infectious Diseases, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2019 - 2026
- ALL3476318
- 181 Pages
- December 2019
- Healthcare
Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in in-vivo studies that involve companion animals. Sponsor companies seek provision from veterinary CROs to support research and development programs for biopharmaceutical industries. Furthermore, different types of services are provided by veterinary CROs such as clinical trials, toxicology, and market authorization & regulatory support. These services are utilized by veterinary medicine manufacturers to test the safety and efficacy of veterinary drugs, which are used in different indications such as oncology, neurology, and infectious diseases.
The factors that boost the growth of the veterinary CRO market include surge in ownership of companion animals and rise in animal health expenditure. Furthermore, other factors such as increase in prevalence of various diseases among companion animal acts as a major factor that contributes toward the growth of the market. However, lack of standardization in veterinary CROs is a factor that restrains the growth of the market. Conversely, surge in awareness related to animal healthcare across the globe is expected to provide lucrative opportunities in the market during the forecast period.
The veterinary CRO market is segmented into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, the market is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, UK and rest of Europe), Asia-Pacific (Japan, China, Australia, rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global veterinary CRO market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative service types facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
• By Service Type
o Clinical Trials
o Toxicology
o Market Authorization & Regulatory Support
o Others
• By Animal Type
o Dogs
o Cats
o Others
• By Indication
o Oncology
o Infectious Disease
o Neurology
o Others
• By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o Australia
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest Of LAMEA
List of key players profiled in the report:
• Charles River Laboratories, Inc.
• Clinvet
• KLIFOVET AG
• Löhlein & Wolf Vet Research
• Oncovet Clinical Research
• ONDAX Scientific
• Triveritas
• Veterinary Research Management (VRM) Ltd
• VetPharm, Inc.
• VETSPIN SRL
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• AlcheraBio
• Likarda
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.1.1. Top Impacting Factors
2.1.2. Top Investment Pockets
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Thereat of New Entrants
3.2.4. Threat of Substitutes
3.2.5. Intensity of Competitive Rivalry
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Surge In Ownership of Companion Animals
3.3.1.2. Rise In Animal Health Expenditure
3.3.1.3. Increase In Prevalence of Various Diseases Among Companion Animals
3.3.2. Restraint
3.3.2.1. Lack of Standardization In Veterinary Cros
3.3.3. Opportunity
3.3.3.1. Surge In Awareness Related To Animal Healthcare
3.3.4. Impact Analysis
Chapter 4: Veterinary Cro Market, By Service Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Clinical Trials
4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis By Country
4.3. Toxicology
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis By Country
4.4. Market Authorization And Regulatory Support
4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis By Country
4.5. Others
4.5.1. Key Market Trends And Growth Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis By Country
Chapter 5: Veterinary Cro Market, By Animal Type
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Dogs
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis By Country
5.3. Cats
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis By Country
5.4. Others
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis By Country
Chapter 6: Veterinary Cro Market, By Indication
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Oncology
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis By Country
6.3. Infectious Disease
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis By Country
6.4. Neurology
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis By Country
6.5. Others
6.5.1. Market Size And Forecast, By Region
6.5.2. Market Analysis By Country
Chapter 7: Veterinary Cro Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends And Opportunities
7.2.2. Market Analysis By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Market Size And Forecast, By Service Type
7.2.2.1.2. U.S. Market Size And Forecast, By Animal Type
7.2.2.1.3. U.S. Market Size And Forecast, By Indication
7.2.2.2. Canada
7.2.2.2.1. Canada Market Size And Forecast, By Service Type
7.2.2.2.2. Canada Market Size And Forecast, By Animal Type
7.2.2.2.3. Canada Market Size And Forecast, By Indication
7.2.2.3. Mexico
7.2.2.3.1. Mexico Market Size And Forecast, By Service Type
7.2.2.3.2. Mexico Market Size And Forecast, By Animal Type
7.2.2.3.3. Mexico Market Size And Forecast, By Indication
7.2.3. North America Market Size And Forecast, By Service Type
7.2.4. North America Market Size And Forecast, By Animal Type
7.2.5. North America Market Size And Forecast, By Indication
7.3. Europe
7.3.1. Key Market Trends And Opportunities
7.3.2. Market Analysis By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Market Size And Forecast, By Service Type
7.3.2.1.2. Germany Market Size And Forecast, By Animal Type
7.3.2.1.3. Germany Market Size And Forecast, By Indication
7.3.2.2. France
7.3.2.2.1. France Market Size And Forecast, By Service Type
7.3.2.2.2. France Market Size And Forecast, By Animal Type
7.3.2.2.3. France Market Size And Forecast, By Indication
7.3.2.3. Uk
7.3.2.3.1. Uk Market Size And Forecast, By Service Type
7.3.2.3.2. Uk Market Size And Forecast, By Animal Type
7.3.2.3.3. Uk Market Size And Forecast, By Indication
7.3.2.4. Italy
7.3.2.4.1. Italy Market Size And Forecast, By Service Type
7.3.2.4.2. Italy Market Size And Forecast, By Animal Type
7.3.2.4.3. Italy Market Size And Forecast, By Indication
7.3.2.5. Spain
7.3.2.5.1. Spain Market Size And Forecast, By Service Type
7.3.2.5.2. Spain Market Size And Forecast, By Animal Type
7.3.2.5.3. Spain Market Size And Forecast, By Indication
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Market Size And Forecast, By Service Type
7.3.2.6.2. Rest of Europe Market Size And Forecast, By Animal Type
7.3.2.6.3. Rest of Europe Market Size And Forecast, By Indication
7.3.3. Europe Market Size And Forecast, By Service Type
7.3.4. Europe Market Size And Forecast, By Animal Type
7.3.5. Europe Market Size And Forecast, By Indication
7.4. Asia-Pacific
7.4.1. Key Market Trends And Opportunities
7.4.2. Market Analysis By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Market Size And Forecast, By Service Type
7.4.2.1.2. Japan Market Size And Forecast, By Animal Type
7.4.2.1.3. Japan Market Size And Forecast, By Indication
7.4.2.2. China
7.4.2.2.1. China Market Size And Forecast, By Service Type
7.4.2.2.2. China Market Size And Forecast, By Animal Type
7.4.2.2.3. China Market Size And Forecast, By Indication
7.4.2.3. Australia
7.4.2.3.1. Australia Market Size And Forecast, By Service Type
7.4.2.3.2. Australia Market Size And Forecast, By Animal Type
7.4.2.3.3. Australia Market Size And Forecast, By Indication
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Service Type
7.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Animal Type
7.4.2.4.3. Rest of Asia-Pacific Market Size And Forecast, By Indication
7.4.3. Asia-Pacific Market Size And Forecast, By Service Type
7.4.4. Asia-Pacific Market Size And Forecast, By Animal Type
7.4.5. Asia-Pacific Market Size And Forecast, By Indication
7.5. Lamea
7.5.1. Key Market Trends And Opportunities
7.5.2. Market Analysis By Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Market Size And Forecast, By Service Type
7.5.2.1.2. Brazil Market Size And Forecast, By Animal Type
7.5.2.1.3. Brazil Market Size And Forecast, By Indication
7.5.2.2. South Africa
7.5.2.2.1. South Africa Market Size And Forecast, By Service Type
7.5.2.2.2. South Africa Market Size And Forecast, By Animal Type
7.5.2.2.3. South Africa Market Size And Forecast, By Indication
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia Market Size And Forecast, By Service Type
7.5.2.3.2. Saudi Arabia Market Size And Forecast, By Animal Type
7.5.2.3.3. Saudi Arabia Market Size And Forecast, By Indication
7.5.2.4. Rest of Lamea
7.5.2.4.1. Rest of Lamea Market Size And Forecast, By Service Type
7.5.2.4.2. Rest of Lamea Market Size And Forecast, By Animal Type
7.5.2.4.3. Rest of Lamea Market Size And Forecast, By Indication
7.5.3. Lamea Market Size And Forecast, By Service Type
7.5.4. Lamea Market Size And Forecast, By Animal Type
7.5.5. Lamea Market Size And Forecast, By Indication
Chapter 8: Competitive Landscape
8.1. Introduction
8.1.1. Market Player Positioning, 2018
8.2. Top Winning Strategies And Key Developments
8.3. Competitive Dashboard
8.4. Competitive Heatmap
Chapter 9: Company Profiles
9.1. Charles River Laboratories, Inc.
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.1.6. Key Strategic Moves And Developments
9.2. Clinvet
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Key Strategic Moves And Developments
9.3. Klifovet Ag
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.4. Löhlein & Wolf Vet Research
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Key Strategic Moves And Developments
9.5. Oncovet Clinical Research
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.6. Ondax Scientific
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Key Strategic Moves And Developments
9.7. Triveritas
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.8. Veterinary Research Management (Vrm) Ltd
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.9. Vetpharm, Inc.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.10. Vetspin Srl
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
Table 01. North America And Europe Veterinary Cro Market, By Service Type, 2016–2026 ($Million)
Table 02. Veterinary Cro Market For Clinical Trials, By Region, 2019–2026 ($Million)
Table 03. Veterinary Cro Market For Toxicology Market, By Region, 2019–2026 ($Million)
Table 04. Veterinary Cro Market For Market Authorization And Regulatory Support Market, By Region 2019–2026 ($Million)
Table 05. Veterinary Cro Market For Others Market, By Region, 2019–2026 ($Million)
Table 06. North America And Europe Veterinary Cro Market, By Animal Type, 2016–2026 ($Million)
Table 07. Veterinary Cro Market For Dogs, By Region, 2019–2026 ($Million)
Table 08. Veterinary Cro Market For Cats, By Region, 2019–2026 ($Million)
Table 09. Veterinary Cro Market For Others, By Region, 2019–2026 ($Million)
Table 10. North America And Europe Veterinary Cro Market, By Indication, 2016–2026 ($Million)
Table 11. Veterinary Cro Market For Oncology, By Region, 2019–2026 ($Million)
Table 12. Veterinary Cro Market For Infectious Disease Market, By Region, 2019–2026 ($Million)
Table 13. Veterinary Cro Market For Neurology, By Region, 2019–2026 ($Million)
Table 14. Veterinary Cro Market For Others, By Region 2019–2026 ($Million)
Table 15. Veterinary Cro Market, By Region, 2018–2026 ($Million)
Table 16. North America Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 17. U.S. Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 18. U.S. Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 19. U.S. Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 20. Canada Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 21. Canada Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 22. Canada Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 23. Mexico Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 24. Mexico Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 25. Mexico Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 26. North America Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 27. North America Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 28. North America Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 29. Europe Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 30. Germany Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 31. Germany Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 32. Germany Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 33. France Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 34. France Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 35. France Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 36. Uk Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 37. Uk Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 38. Uk Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 39. Italy Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 40. Italy Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 41. Italy Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 42. Spain Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 43. Spain Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 44. Spain Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 45. Rest of Europe Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 46. Rest of Europe Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 47. Rest of Europe Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 48. Europe Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 49. Europe Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 50. Europe Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 51. Asia-Pacific Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 52. Japan Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 53. Japan Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 54. Japan Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 55. China Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 56. China Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 57. China Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 58. Australia Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 59. Australia Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 60. Australia Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 61. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 62. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 63. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 64. Asia-Pacific Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 65. Asia-Pacific Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 66. Asia-Pacific Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 67. Lamea Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 68. Brazil Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 69. Brazil Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 70. Brazil Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 71. South Africa Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 72. South Africa Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 73. South Africa Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 74. Saudi Arabia Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 75. Saudi Arabia Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 76. Saudi Arabia Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 77. Rest of Lamea Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 78. Rest of Lamea Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 79. Rest of Lamea Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 80. Lamea Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 81. Lamea Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 82. Lamea Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 83. Charles River Laboratories, Inc.: Company Snapshot
Table 84. Charles River Laboratories, Inc.: Operating Segments
Table 85. Charles River Laboratories, Inc. Plc: Product Portfolio
Table 86. Clinvet: Company Snapshot
Table 87. Clinvet Inc.: Operating Segments
Table 88. Clinvet Inc.: Product Portfolio
Table 89. Klifovet Ag: Company Snapshot
Table 90. Klifovet Ag: Operating Segments
Table 91. Klifovet Ag: Product Portfolio:
Table 92. Löhlein & Wolf Vet Research: Company Snapshot
Table 93. Löhlein & Wolf Vet Research: Operating Segments
Table 94. Löhlein & Wolf Vet Research: Product Portfolio
Table 95. Oncovet Clinical Research: Company Snapshot
Table 96. Oncovet Clinical Research: Operating Segments
Table 97. Oncovet Clinical Research: Product Portfolio
Table 98. Ondax Scientific: Company Snapshot
Table 99. Ondax Scientific: Operating Segments
Table 100. Ondax Scientific: Product Portfolio
Table 101. Triveritas: Company Snapshot
Table 102. Triveritas: Operating Segments
Table 103. Triveritas: Product Portfolio
Table 104. (Vrm): Company Snapshot
Table 105. Vrm: Operating Segments
Table 106. Vrm: Product Portfolio
Table 107. Vetpharm, Inc.: Company Snapshot
Table 108. Vetpharm, Inc.: Product Segments
Table 109. Vetpharm, Inc.: Product Portfolio
Table 110. Vetspin Srl.: Company Snapshot
Table 111. Vetspin Srl.: Operating Segments
Table 112. Vetspin Srl: Product Portfolio
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
